Valvular heart disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Clinically stable patients with valvular heart disease who are undergoing cardiac catheterization 20 years of age or older Patients who have signed consent forms
Exclusion criteria
Exclusion criteria: Significant stenosis in the left anterior descending artery (LAD), prior myocardial infarction in the LAD territory, acute decompensated heart failure, acute coronary syndrome, pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluating the differences in the index of microcirculatory resistance (IMR) between patients with valvular heart disease (VHD group) and those without valvular heart disease (Non-VHD group) | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluating the differences in coronary flow reserve (CFR) and fractional flow reserve (FFR) between VHD group and Non-VHD group Comparing the number of abnormal IMR and abnormal CFR between VHD group and Non-VHD group Evaluating the relationship between IMR, CFR and FFR and the findings on cardiac catheterization and echocardiography Evaluating the relationship between IMR, CFR and FFR and clinical events Comparison of coronary physiological measurements (IMR, CFR and FFR) between groups divided according to ejection fractions or types of valvular heart disease (i.e. aortic stenosis, aortic regurgitation, mitral stenosis and mitral regurgitation) Evaluating the relationship between RHI and coronary physiological measurements (IMR, CFR and FFR) in the VHD group and non-VHD group. | — |
Countries
Japan
Contacts
Chiba University Hospital Department of Cardiovascular Medicine